2016 annual financial data

TG Therapeutics 2016 Net margin

Direct answer

Net margin was -51,353.45%.

Operating income was -78,969,128 USD and net income was -78,252,894 USD.
Operating cash flow was -61,591,330 USD.

Get free TG Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
152,381 USD
Operating income
-78,969,128 USD
Net income
-78,252,894 USD
Operating cash flow
-61,591,330 USD